-
1
The FDA has authorized Zyn to market 20 of its nicotine pouches as safer than cigarettes, claiming reduced risks for several health conditions.
-
2
Zyn's sales reached 794 million cans last year, more than doubling its total from 2023, indicating a surge in popularity.
-
3
Health organizations, including the American Cancer Society, express concern over Zyn's marketing to young people and its addictive nature.
-
4
Lisa Licasse from the American Cancer Society warns that the tobacco industry targets a new generation with flavored products.
-
5
The FDA's decision follows a broader trend of regulatory changes benefiting the tobacco industry, including the return of flavored vapes.